Skip to main content

Table 3 Incidence of venous thrombosis in patients with various baseline characteristics

From: Dose-dependent effects of heparin sodium injection in preventing peripherally inserted central catheter-related venous thrombosis during postoperative chemotherapy in non-small cell lung carcinoma patients

Baseline characteristics

Venous thrombosis (n = 42)

No venous thrombosis(n = 383)

P value

Group

  

< 0.001

Control group

28 (66.67)

112 (29.24)

 

Group I

11 (26.19)

131 (34.20)

 

Group II

3 (7.14)

140 (36.55)

 

Age (years)

  

0.373

≤ 63

20 (47.62)

210 (54.83)

 

> 63

22 (52.38)

173 (45.17)

 

Sex

  

0.218

Male

34 (80.95)

276 (72.06)

 

Female

8 (19.05)

107 (27.94)

 

Weight (kg)

  

0.356

≤ 62 kg

20 (47.62)

211 (55.09)

 

> 62 kg

22 (52.38)

172 (44.91)

 

Smoking

  

0.528

Yes

22 (52.38)

181 (47.26)

 

No

20 (47.62)

202 (52.74)

 

ECOG score

  

0.752

0

10 (23.81)

106 (27.68)

 

1

19 (45.24)

151 (39.43)

 

2

13 (30.95)

126 (32.90)

 

Pathology type

  

0.354

Squamous carcinoma

24 (57.14)

190 (49.61)

 

Adenocarcinoma

18 (42.86)

193 (50.39)

 

Disease staging

  

0.389

I

1 (2.38)

35 (9.14)

 

II

6 (14.29)

59 (15.40)

 

III

11 (26.19)

110 (28.72)

 

IV

24 (57.14)

179 (46.74)

 

Operation type

  

0.613

Sublobar resection

23 (54.76)

194 (50.65)

 

Lobectomy

19 (45.24)

189 (49.35)

Â